UPDATE
We have renewed our investigation into the fairness of the proposed sale of Kennedy-Wilson Holdings (NYSE: KW) (“KW”) for $10.90 per share in cash in a take-private transaction led by KW’s CEO William McMorrow and senior management, along with Fairfax Financial Holdings Limited (“Fairfax”), KW’s largest shareholder.
The sale price is only a modest premium over KW’s closing price of $9.89 per share on February 13, 2026, the last trading day before the deal was announced on February 17, 2026.
We have renewed our investigation of the proposed sale after reviewing the definitive proxy (“Proxy”) filed by KW with the SEC on May 5, 2026, soliciting KW stockholders to approve the proposed sale at a vote presently scheduled for June 10, 2026.
According to the Proxy, as of May 1, 2026, McMorrow owned 8.4% of KW’s outstanding common stock, and Fairfax owned 19.9% of KW’s outstanding common stock.
The sale was approved upon the recommendation of a purportedly independent special committee of the KW board of directors.
If you remain a KW shareholder and have concerns about the fairness of the sale price, you may contact our firm to discuss your legal rights at no charge by completing and submitting the form below.
With the upcoming vote, we encourage KW shareholders to contact our firm as soon as possible if they have any concerns about the sale price.
ORIGINAL ANNOUNCEMENT
We are investigating the fairness of the proposed sale of Kennedy-Wilson Holdings (NYSE: KW) (“KW”) for $10.90 per share in cash in a take-private transaction led by KW’s CEO William McMorrow and senior management, along with Fairfax Financial Holdings Limited (“Fairfax”), KW’s largest shareholder.
As of KW’s last annual proxy filed with the SEC on April 25, 2025, McMorrow owned 8.5% of KW’s outstanding common stock, and Fairfax owned 19.9% of KW’s outstanding common stock.
The sale was approved upon the recommendation of a purportedly independent special committee of the KW board of directors.
The sale price is only a modest premium over KW’s closing price of $9.89 per share on February 13, 2026, and below the price target of $11.00 per share set by J.P. Morgan analyst Anthony Paolone on December 18, 2025.
If you remain a KW shareholder and have concerns about the fairness of the price, you may contact our firm to discuss your legal rights at no charge by completing and submitting the form below.
“We are investigating whether the Special Committee acted in the best interests of KW shareholders in recommending the sale,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter. “This includes whether the members of the Special Committee were truly independent, whether the sale price is fair to KW shareholders, and whether all material information regarding the transaction has been fully disclosed. We encourage KW shareholders to contact the firm if they have any concerns.”